Ramipril Capsule
Product Images NDC 63629-1254

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Ramipril (NDC 63629-1254). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl636291254)

Ramipril 5 mg capsule packaging label from Bryant Ranch Prepack, showing the product name and strength prominently. The label mentions comparison to Altace 5 mg Capsule by Aurobindo Pharma Limited. It indicates a package count of 30 capsules, includes a barcode, lot number 106962, and storage instructions to keep at 20-25°C (68-77°F) and out of reach of children. The label also shows the NDC number 63629-1254-1.*

FDA Label Image

Ramipril Fig1

A line graph depicting the proportion of patients over days of follow-up comparing Ramipril and placebo groups. The x-axis represents days of follow-up up to about 1600 days; the y-axis represents the proportion of patients from 0.00 to 0.20. The graph shows two lines: a solid line for Ramipril and a dashed line for placebo, with the placebo group having a higher proportion. The p-value of 0.0001 is indicated on the graph.*

FDA Label Image

Ramipril Fig2

A forest plot chart showing the relative risk of composite outcomes in a Ramipril group compared to a placebo group across various patient subgroups, including cardiovascular disease, diabetes, age, sex, hypertension, history of coronary artery disease, myocardial infarction, cerebrovascular disease, peripheral vascular disease, and microalbuminuria. The chart displays number of patients, incidence rates in placebo, and confidence intervals for relative risk.*

FDA Label Image

Chemical Structure (Ramipril Str)

Chemical structure diagram of Ramipril, showing its molecular composition and bonds as depicted in the image.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.